Novadaq Technologies Inc. (NVDQ)

Check out top investors' recommendation for NVDQ
Last closing price (Apr 23 4:00 EDT):
17.34 (-5.50%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
-7.96% ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Novadaq Technologies Inc. develops, manufactures, and commercializes fluorescence imaging products and therapeutic devices for surgeons in the operating room and other clinical settings primarily in the United States, Japan, and internationally. The company’s proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. Its SPY—inpatient open surgical imaging system, including SPY and SPY Elite are used in coronary artery bypass graft surgery, cardiovascular surgery, plastic surgery, reconstructive surgery, microsurgery, organ transplant, and gastrointestinal surgery. The company’s LUNA – diagnostic outpatient imaging system enables physicians treating chronic wounds for the treatment of diabetic foot ulcers, pressure sores, and other serious wounds. Its FIREFLY—robotic surgical imaging system is used for robotic surgery; and PINPOINT—endoscopic fluorescence imaging system is used for traditional endoscope and to obtain fluorescence images on demand or in a simultaneous imaging mode during minimally invasive surgery. The company also offers SPY analysis toolkit, a post-processing software that allows surgeons to apply objective analysis tools to SPY, SPY Elite, and LUNA images; and CO2 heart laser systems for transmyocardial revascularization. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Jason Mills Canaccord Genuity Buy   Apr 04, '14   20.81  26.00  Apr 04, '15  -16.67% 
Jason Mills Canaccord Genuity Buy   Oct 23, '13   18.72    Oct 23, '14  -7.37% 
Ben Haynor Feltl & Company Buy   Sep 27, '13   16.66  18.50  Sep 27, '14  11.04% 
Juan Noble Taglich Brothers Inc. Buy   Feb 21, '13   8.80  11.60  Feb 21, '14  132.16% 
Jason Mills Canaccord Genuity Buy   Oct 18, '12   11.46  15.00  Oct 18, '13  48.08% 
Suraj Kalia Northland Sec Sell   Oct 17, '12   11.91  6.00  Oct 17, '13  -42.32% 
Dalton Chandler Needham & Company Buy   Aug 03, '12   8.16    Aug 03, '13  64.83% 
Ben Haynor Feltl & Company Buy   Jun 21, '12   5.57  8.50  Jun 21, '13  135.91%